Chamber and committees

An update on the work of the multidisciplinary team of senior clinicians within the office of the Chief Medical Officer considering the specific clinical recommendations of the Cass review will be provided to the National Gender Identity Healthcare Reference Group at a future meeting.

The Scottish Government is working with Public Health Scotland to identify what data is already collected in Scotland on metastatic breast cancer and what data we would like to expand our datasets to include going forward.

The Scottish Government is reviewing options in relation to collecting data on secondary breast cancer in Scotland. This includes consideration of the NHS England audit, data available in Scotland, clinical time required, other cancer data priorities and how it can be used to improve services.

The Scottish Government has followed the publication of the National Audit of Metastatic Breast Cancer for England and Wales with interest. We are working with Public Health Scotland to determine our options for future data collection on metastatic breast cancer and its publication.

The following table shows the resource funding allocated by SG to ILF Scotland annually over the last five years. Resource budget for ILF in 2024-25 is £62,241k. Funding for 2025-26 will be agreed through the annual budget process.

As of March 2024, 1,897 people in Scotland, and 344 people in Northern Ireland were in receipt of an Independent Living Fund award. These figures do not include Transition Fund awards.

Up to 1,000 new applicants will be offered awards in 2024-25. The actual number of applications received will be monitored by ILF Scotland and Scottish Government.

The Scottish Government, along with Health Boards and the Centre for Sustainable Delivery (CfSD), is actively considering opportunities to allocate funding to deliver activity utilising the £30 million investment announced by the First Minister on 1 April. This funding is being targeted at a series of national and local plans to reduce backlogs in orthopaedics, ophthalmology, diagnostics and cancer backlog by maximising the use of local and national resources across Scotland.

Once we have concluded this process we will provide a breakdown of how the funding has been allocated by Health Board.

The initial £30 million of targeted investment is the first instalment of a £300 million plan over the next three years to help reduce waiting lists, subject to the Scottish Budget process.

Decisions on the Government’s spending plans for future years are subject to the outcome of the annual Scottish Budget setting process and associated approval by the Scottish Parliament. In-year revisions to the 2024-25 Scottish Budget are subject to parliamentary approval in the same way.

The Scottish Government, along with Health Boards and the Centre for Sustainable Delivery (CfSD), is actively considering opportunities to allocate funding to deliver activity utilising the £30 million investment announced by the First Minister on 1 April. This funding is being targeted at a series of national and local plans to reduce backlogs in orthopaedics, ophthalmology, diagnostics and cancer backlog by maximising the use of local and national resources across Scotland.

Once we have concluded this process we will provide a breakdown of how the funding has been allocated by Health Board.

The initial £30 million of targeted investment is the first instalment of a £300 million plan over the next three years to help reduce waiting lists, subject to the Scottish Budget process.

Decisions on the Government’s spending plans for future years are subject to the outcome of the annual Scottish Budget setting process and associated approval by the Scottish Parliament. In-year revisions to the 2024-25 Scottish Budget are subject to parliamentary approval in the same way.

The Scottish Government, along with Health Boards and the Centre for Sustainable Delivery (CfSD), is actively considering opportunities to allocate funding to deliver activity utilising the £30 million investment announced by the First Minister on 1 April. This funding is being targeted at a series of national and local plans to reduce backlogs in orthopaedics, ophthalmology, diagnostics and cancer backlog by maximising the use of local and national resources across Scotland.

Once we have concluded this process we will provide a breakdown of how the funding has been allocated by Health Board.

The initial £30 million of targeted investment is the first instalment of a £300 million plan over the next three years to help reduce waiting lists, subject to the Scottish Budget process.

Decisions on the Government’s spending plans for future years are subject to the outcome of the annual Scottish Budget setting process and associated approval by the Scottish Parliament. In-year revisions to the 2024-25 Scottish Budget are subject to parliamentary approval in the same way.